Open Access
SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations)
Nadia Howlader,AM Noone,Martin Krapcho,N Neyman,R Aminou,Sean F. Altekruse,CL Kosary,Jennifer Ruhl,Z. Tatalovich,H Cho,Angela B. Mariotto,M. P. Eisner,Lewis,HS Chen,Eric J. Feuer,Kathleen A. Cronin,Anne-Michelle Noone,K. W. Waldron,S Mariotto +18 more
Reads0
Chats0
About:
The article was published on 2012-01-01 and is currently open access. It has received 1426 citations till now.read more
Citations
More filters
Book ChapterDOI
Breast Cancer Statistics
Jiemin Ma,Ahmedin Jemal +1 more
TL;DR: Breast cancer rates vary largely by race/ethnicity and socioeconomic status (SES), and geographic region, and death rates are higher in African American women than in whites, despite their lower incidence rates.
Journal ArticleDOI
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C. Wolff,M. Elizabeth H. Hammond,David G. Hicks,Mitch Dowsett,Lisa M. McShane,Kimberly H. Allison,D. C. Allred,John M. S. Bartlett,Michael Bilous,Patrick L. Fitzgibbons,Wedad Hanna,Robert B. Jenkins,Pamela B. Mangu,Soonmyung Paik,Edith A. Perez,Michael F. Press,Patricia A. Spears,Gail H. Vance,Giuseppe Viale,Daniel F. Hayes +19 more
TL;DR: The Update Committee recommends that HER2 status (HER2 negative or positive) be determined in all patients with invasive breast cancer on the basis of one or more HER2 test results (negative, equivocal, or positive).
Journal ArticleDOI
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff,M. Elizabeth H. Hammond,David G. Hicks,Mitch Dowsett,Lisa M. McShane,Kimberly H. Allison,D. C. Allred,John M. S. Bartlett,Michael Bilous,Patrick L. Fitzgibbons,Wedad Hanna,Robert B. Jenkins,Pamela B. Mangu,Soonmyung Paik,Edith A. Perez,Michael F. Press,Patricia A. Spears,Gail H. Vance,Giuseppe Viale,Daniel F. Hayes +19 more
TL;DR: The Update Committee recommends that HER2 status (HER2 negative or positive) be determined in all patients with invasive breast cancer on the basis of one or more HER2 test results (negative, equivocal, or positive).
Journal ArticleDOI
Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Alison W. Loren,Pamela B. Mangu,Lindsay Nohr Beck,Lawrence V. Brennan,Anthony J. Magdalinski,Ann H. Partridge,Gwendolyn P. Quinn,W. Hamish B. Wallace,Kutluk Oktay,Anthony J. Magda,Nohr Beck +10 more
TL;DR: Health care providers should address the possibility of infertility with patients treated during their reproductive years and be prepared to discuss fertility preservation options and/or to refer all potential patients to appropriate reproductive specialists.
Journal ArticleDOI
ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
Sapna Syngal,Randall E. Brand,James M. Church,Francis M. Giardiello,Heather Hampel,Randall W. Burt +5 more
TL;DR: Patients who meet clinical criteria for a syndrome as well as those with identified pathogenic germline mutations should receive appropriate surveillance measures in order to minimize their overall risk of developing syndrome-specific cancers.
Related Papers (5)
AJCC Cancer Staging Manual
Mahul B. Amin,Stephen B. Edge,Frederick L. Greene,David R. Byrd,Robert K. Brookland,Mary Kay Washington,Jeffrey E. Gershenwald,Carolyn C. Compton,Kenneth R. Hess,Daniel C. Sullivan,J. Milburn Jessup,James D. Brierley,Lauri E. Gaspar,Richard L. Schilsky,Charles M. Balch,David P. Winchester,Elliot A. Asare,Martin Madera,Donna M. Gress,Laura R. Meyer +19 more